Patents by Inventor Julien Georges Doyon

Julien Georges Doyon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070244138
    Abstract: The present invention relates to a compound of formula (I) a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine or a stereochemically isomeric form thereof, wherein R1 represents hydrogen, C1-6alkyl, C3-7cycloalkyl, C1-6alkyloxyC1-6alkyl, di(C1-6alkyl)aminoC1-6alkyl, aryl or heteroaryl; each R2 independently represents halo, C1-6alkyl, C1-6alkyloxy, C1-6alkylthio, polyhaloC1-6alkyl, polyhaloC1-6alkyloxy, cyano, aminocarbonyl, amino, mono- or di(C1-4alkyl) amino, nitro, aryl or aryloxy; R3 represents hydrogen, cyano, optionally substituted C1-6alkyl, C(?O)—O—R5, C(?O)—NR6aR6b, C(?S)—NR6aR6b, S(?O)2—NR6aR6b or C(?O)—R7; R4 represents hydrogen or C1-6alkyl; n is 1, 2, 3, 4 or 5; Z represents a cyclic ring system. The invention also relates to processes for preparing the compounds of formula (I), their use as CCR2 antagonists and pharmaceutical compositions comprising them.
    Type: Application
    Filed: May 24, 2005
    Publication date: October 18, 2007
    Applicant: JANSSEN PHARMACEUTICA N.V.
    Inventors: Gustaaf Boeckx, Guy Van Lommen, Julien Georges Doyon, Erwin Coesemans
  • Publication number: 20070203189
    Abstract: This invention concerns the use of a compound of formula (I?) a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine and a stereochemically isomeric form thereof, wherein Z is halo; C1-6alkyl; C1-6alkylcarbonyl; C1-6alkyloxycarbonyl; aminocarbonyl; C1-6alkyl substituted with hydroxy, carboxyl, cyano, amino, amino substituted with piperidinyl, amino substituted with C1-4alkyl substituted piperidinyl, mono- or di(C1-6alkyl)amino, aminocarbonyl, mono- or di(C1-6alkyl)aminocarbonyl, C1-6alkyloxycarbonyl, C1-6alkyloxy, piperidinyl, piperazinyl, morpholinyl, thiomorpholinyl; polyhaloC1-4alkyl; cyano; amino; mono- or di(C1-6alkyl)aminocarbonyl; C1-6alkyloxycarbonyl; C1-6alkylcarbonyloxy; aminoS(?O)2—; mono- or di(C1-6alkyl)aminoS(?O)2; —C(?N—Rx)NRyRz; Q is optionally substituted C3-6cycloalkyl, phenyl, pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl, benzthiazolyl, benzoxazolyl, benzimidazolyl, indazolyl, or imidazopyridyl, or Q is a radical of formula L is optionally substituted phenyl or a
    Type: Application
    Filed: May 1, 2007
    Publication date: August 30, 2007
    Inventors: Christopher Love, Guy Van Lommen, Julien Georges Doyon, Jean-Pierre Bongartz, Marcel Van der Aa, Robert Hendrickx, Peter Jacobus Antonius Buijnsters, Ludwig Cooymans, Nele Vandermaesen, Erwin Coesemans, Gustaaf Boeckx
  • Publication number: 20060058289
    Abstract: The present invention relates to a compound of formula (I) having CCR2 receptor antagonistic properties, particularly anti-infflammatory properties.
    Type: Application
    Filed: January 30, 2004
    Publication date: March 16, 2006
    Applicant: Janssen Pharmaceutica, N.V.
    Inventors: Guy Van Lommen, Julien Georges Doyon, Jean Van Wauwe, Marina Cools, Erwin Coesemans